Tekmira announces leadership changes

Tekmira Pharmaceuticals (TKMR) announces some leadership changes.

Dr. Michael Abrams will become Executive VP and Chief Discovery Officer (he will resign as independent director).

A new unit focused on "medical countermeasures" will be led by Dr. Ian MacLachlan, who will also become Executive VP and Chief Technical Officer. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs